CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 28, 2026	Mar. 29, 2025	Mar. 28, 2026	Mar. 29, 2025
Income Statement [Abstract]
Net sales	$ 89,571	$ 111,974	$ 284,640	$ 357,385
Cost of sales	82,388	103,367	268,643	327,769
Gross profit	7,183	8,607	15,997	29,616
Research, development and engineering expenses	1,825	2,308	5,748	6,917
Selling, general and administrative expenses	6,233	6,758	21,966	19,835
Gain on insurance proceeds, net of losses	(637)	0	(637)	0
Total operating expenses	7,421	9,066	27,077	26,752
Operating income (loss)	(238)	(459)	(11,080)	2,864
Interest expense, net	2,396	2,581	7,543	9,748
Loss before income taxes	(2,634)	(3,040)	(18,623)	(6,884)
Income tax benefit	(9)	(2,436)	(5,173)	(2,490)
Net loss	$ (2,625)	$ (604)	$ (13,450)	$ (4,394)
Net loss per share — Basic (in USD per share)	$ (0.24)	$ (0.06)	$ (1.24)	$ (0.41)
Weighted average shares outstanding — Basic (in shares)	10,859	10,762	10,830	10,762
Net loss per share — Diluted (in USD per share)	$ (0.24)	$ (0.06)	$ (1.24)	$ (0.41)
Weighted average shares outstanding — Diluted (in shares)	10,859	10,762	10,830	10,762